Operating Lease, Right-of-Use Asset of AYTU BIOPHARMA, INC from 30 Jun 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
AYTU BIOPHARMA, INC quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 30 Jun 2019 to 31 Dec 2025.
  • AYTU BIOPHARMA, INC Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $959,000, a 19% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

AYTU BIOPHARMA, INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $959,000 -$219,000 -19% 31 Dec 2025 10-Q 03 Feb 2026 2026 Q2
Q3 2025 $1,010,000 -$215,000 -18% 30 Sep 2025 10-Q 13 Nov 2025 2026 Q1
Q2 2025 $1,061,000 +$232,000 +28% 30 Jun 2025 10-Q 03 Feb 2026 2026 Q2
Q1 2025 $1,111,000 -$684,000 -38% 31 Mar 2025 10-Q 14 May 2025 2025 Q3
Q4 2024 $1,178,000 -$955,000 -45% 31 Dec 2024 10-Q 12 Feb 2025 2025 Q2
Q3 2024 $1,225,000 -$1,229,000 -50% 30 Sep 2024 10-Q 13 Nov 2024 2025 Q1
Q2 2024 $829,000 -$1,225,000 -60% 30 Jun 2024 10-K 23 Sep 2025 2025 FY
Q1 2024 $1,795,000 -$572,000 -24% 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 $2,133,000 -$542,000 -20% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q2
Q3 2023 $2,454,000 -$522,000 -18% 30 Sep 2023 10-Q 14 Nov 2023 2024 Q1
Q2 2023 $2,054,000 -$1,217,000 -37% 30 Jun 2023 10-K 26 Sep 2024 2024 FY
Q1 2023 $2,367,000 -$1,194,000 -34% 31 Mar 2023 10-Q 11 May 2023 2023 Q3
Q4 2022 $2,675,000 -$1,170,000 -30% 31 Dec 2022 10-Q 21 Feb 2023 2023 Q2
Q3 2022 $2,976,000 -$850,000 -22% 30 Sep 2022 10-Q/A 21 Feb 2023 2023 Q1
Q2 2022 $3,271,000 -$292,000 -8.2% 30 Jun 2022 10-K 12 Oct 2023 2023 FY
Q1 2022 $3,561,000 -$220,737 -5.8% 31 Mar 2022 10-Q 16 May 2022 2022 Q3
Q4 2021 $3,845,000 +$3,534,521 +1138% 31 Dec 2021 10-Q 14 Feb 2022 2022 Q2
Q3 2021 $3,826,000 +$3,491,711 +1045% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q1
Q2 2021 $3,563,000 +$2,929,000 +462% 30 Jun 2021 10-K 27 Sep 2022 2022 FY
Q1 2021 $3,781,737 +$3,105,757 +459% 31 Mar 2021 10-Q 17 May 2021 2021 Q3
Q4 2020 $310,479 -$64,089 -17% 31 Dec 2020 10-Q 11 Feb 2021 2021 Q2
Q3 2020 $334,289 -$59,531 -15% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q1
Q2 2020 $634,000 +$634,000 30 Jun 2020 10-K 28 Sep 2021 2021 FY
Q1 2020 $675,980 31 Mar 2020 10-Q 15 May 2020 2020 Q3
Q4 2019 $374,568 31 Dec 2019 10-Q 14 Feb 2020 2020 Q2
Q3 2019 $393,820 30 Sep 2019 10-Q 14 Nov 2019 2020 Q1
Q2 2019 $0 30 Jun 2019 10-K 06 Oct 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.